Application of 189028-95-3, Academic researchers, R&D teams, teachers, students, policy makers and the media all rely on us to share knowledge that is reliable, accurate and cutting-edge. In a Patent，once mentioned of 189028-95-3
The application discloses one intermediate folds Mai Bu 3 – [(2R, 5S) – 5 – (4-fluoro phenyl) – 2 – [(S) – [(4-fluoro phenyl (amino)]] [4-R 1 oxy] phenyl] methyl] – 1-oxo-5 – [( trimethyl silicon ) oxy] phenyl] – 4-phenyl-(4S) – 2-oxazolidinone continuous production method, characterized in that the compound containing compound and A B raw material, in the slurry bed reactor is contacted with a solid acid catalyst in the reaction, the preparation intermediates mai Bustates according to the booklet. Through the use of solid acid catalyst to replace the original titanium tetrachloride and isopropyl alcohol titanium catalyst, and the continuous reaction slurry bed reactor, reduces the environmental pollution and to the requirements of the production equipment, solves the problem of separation and recovery of the catalyst, the scale continuous production of mai Buaccording to booklet become possible. (by machine translation)
The design and synthesis of related molecules that are more effective, more selective, and less toxic than aspirin are important objectives of biomedical research.Keep reading other articles of 189028-95-3Application of 189028-95-3
Reference：
Oxazolidine – Wikipedia,
Oxazolidine | C3H2846NO – PubChem